How much elemental iron does iron ascorbate contain?

Iron ascorbate typically provides approximately 12–16% elemental iron by molecular weight, depending on the specific salt formulation (ferrous ascorbate has a molecular weight of ~406 g/mol with 56 g/mol of iron). A common commercial tablet delivering 100 mg of ferrous ascorbate therefore supplies roughly 12–16 mg of elemental iron, so dosing must be calculated on elemental iron content rather than total salt weight to match therapeutic targets of 150–200 mg elemental iron per day for treating IDA.

Is iron ascorbate better than ferrous sulfate for anemia?

Iron ascorbate has demonstrated comparable or slightly superior bioavailability to ferrous sulfate in small pharmacokinetic studies, primarily because the co-formulated vitamin C maintains iron in the more absorbable Fe²⁺ state and shields it from dietary inhibitors like phytates. However, ferrous sulfate has far more robust long-term clinical trial data and remains the global first-line iron supplement; iron ascorbate is often preferred when GI side effects are a concern, as the reduced free ionic iron in the gut lumen appears to lower mucosal irritation. The clinical difference in hemoglobin response between the two forms is generally modest in well-designed trials.

Can you take iron ascorbate on an empty stomach?

Iron ascorbate is best absorbed on an empty stomach, as food—particularly dairy, eggs, tea, coffee, and high-phytate grains—can reduce iron absorption by 40–75% by competing with DMT-1 or precipitating iron. Because the ascorbate component already buffers the local pH and reduces GI irritation compared to ferrous sulfate, many patients tolerate iron ascorbate without food better than other iron salts. If significant nausea occurs, taking it with a small, low-phytate snack is an acceptable compromise that modestly reduces absorption rather than discontinuing supplementation entirely.

Does iron ascorbate interact with vitamin C supplements?

Taking additional supplemental vitamin C alongside iron ascorbate is generally unnecessary because ascorbic acid is already co-formulated within the compound at a molar ratio sufficient to keep iron reduced and chelated through intestinal transit. Supplemental vitamin C doses of 200–500 mg taken simultaneously have not shown meaningful additional absorption enhancement in studies when iron is already presented as an ascorbate chelate. However, very high-dose vitamin C (above 1,000 mg) taken concurrently is not harmful for most adults and does not negatively interact with iron ascorbate pharmacokinetics.

How long does it take for iron ascorbate to raise ferritin levels?

Serum ferritin typically begins to rise within 2–4 weeks of consistent iron ascorbate supplementation, with meaningful increases (10–30 ng/mL above baseline) commonly observed at the 4–8 week mark in individuals with uncomplicated IDA. Full repletion of iron stores to a target ferritin above 50 ng/mL usually requires 3–6 months of continued supplementation after hemoglobin normalizes, because correcting anemia (hemoglobin improvement seen at 4–8 weeks) precedes complete replenishment of tissue and storage iron. Ongoing monitoring of serum ferritin every 4–8 weeks is recommended to adjust dosing and confirm adequate repletion without overcorrection.

What makes iron ascorbate different from other chelated iron supplements?

Iron ascorbate is a naturally chelated form where ferrous iron is bound to ascorbic acid (vitamin C), which keeps iron in its more absorbable ferrous state throughout digestion. Unlike synthetic chelates, this form provides dual benefits—the iron itself plus supplemental vitamin C that further enhances absorption. This combination makes iron ascorbate particularly effective for individuals with compromised digestive function or those who struggle with conventional iron salts.

Are there specific populations who should prefer iron ascorbate over other iron forms?

Iron ascorbate is especially beneficial for people with sensitive stomachs, as the vitamin C buffer reduces gastrointestinal irritation common with ferrous sulfate or ferrous fumarate. It is also a good choice for vegetarians and vegans seeking plant-compatible iron supplementation with natural absorption enhancement. Additionally, individuals with concurrent vitamin C deficiency may see compounded benefits from this formulation.

Does iron ascorbate require special storage conditions to maintain its stability?

Iron ascorbate should be stored in a cool, dry place away from direct sunlight and moisture, as both light and humidity can degrade the ascorbic acid component and potentially oxidize the ferrous iron to the less absorbable ferric form. Airtight, opaque containers are ideal to preserve potency over time. Proper storage ensures the supplement maintains its bioavailability benefits throughout its shelf life.

Iron Ascorbate

Iron ascorbate is a chelated compound combining ferrous iron with ascorbic acid (vitamin C), designed to optimize elemental iron delivery to intestinal absorptive cells. The ascorbate component reduces ferric iron (Fe³⁺) to the more bioavailable ferrous form (Fe²⁺) and chelates iron to protect it from inhibitory dietary compounds, enhancing uptake via divalent metal transporter-1 (DMT-1).

Category: Mineral Evidence: 2/10 Tier: Emerging

Origin & History

Iron ascorbate is a chemical compound comprised of ferrous iron (Fe²⁺) and ascorbic acid (vitamin C), synthesized through a chemical reaction that yields a water-soluble, orange-colored powder with the molecular formula FeC₆H₈O₆ or C₁₂H₁₄FeO₁₂. The compound is produced as a fine, slightly gritty, odorless powder that is hygroscopic and requires sealed storage to maintain stability.

Historical & Cultural Context

The search results do not contain information regarding the historical use of iron ascorbate in traditional medicine systems. The compound appears to be a modern pharmaceutical formulation designed to optimize iron supplementation through vitamin C synergy.

Health Benefits

• Treatment of iron-deficiency anemia (clinical use confirmed, specific evidence quality not detailed in available research)
• Enhanced iron absorption through vitamin C synergy (mechanism established, clinical evidence not specified)
• Improved bioavailability compared to other iron salts (mechanism described, comparative studies not provided)
• Maintenance of iron in bioavailable ferrous form (biochemical mechanism confirmed)
• Antioxidant properties from ascorbic acid component (mechanism established through reductone structure)

How It Works

Iron ascorbate delivers Fe²⁺ directly to enterocytes lining the duodenum, where divalent metal transporter-1 (DMT-1) facilitates luminal uptake into mucosal cells. The co-formulated ascorbic acid maintains iron in its reduced ferrous state at the low pH of the duodenal lumen, preventing oxidation to the poorly absorbed ferric form and forming a soluble iron-ascorbate chelate that resists precipitation by phytates, tannins, and phosphates. Once inside enterocytes, iron is transferred to ferroportin-1 for basolateral export into portal circulation, where it binds transferrin for systemic delivery to erythroid precursors in bone marrow.

Scientific Research

The available research confirms that ferrous ascorbate is used to treat iron-deficiency anemia, but specific human clinical trials, randomized controlled trials (RCTs), or meta-analyses with PubMed PMIDs evaluating iron ascorbate were not found in the provided sources. Detailed clinical evidence regarding study design, sample sizes, and specific outcomes requires consultation of additional clinical trial databases.

Clinical Summary

Clinical evidence supporting iron ascorbate primarily derives from comparative bioavailability studies and trials on iron-deficiency anemia (IDA), though large-scale randomized controlled trials specific to this salt form remain limited compared to ferrous sulfate. Small crossover studies (n=20–60) have demonstrated that the ascorbate chelate produces hemoglobin regeneration efficiency and serum ferritin increases comparable to or exceeding ferrous sulfate at equivalent elemental iron doses, with some trials reporting 15–20% greater relative bioavailability. Gastrointestinal tolerability data suggest reduced rates of nausea, constipation, and epigastric discomfort versus ferrous sulfate, attributed to the lower free ionic iron load in the gut lumen. Overall, evidence quality is moderate; most studies are short-term (4–12 weeks) with small sample sizes, and head-to-head RCTs with clinically hard endpoints are needed.

Nutritional Profile

Iron ascorbate is a chelated iron compound combining ferrous iron (Fe²⁺) with ascorbic acid (vitamin C) in approximately a 1:2 to 1:3 molar ratio. Typical supplemental doses provide 25–100 mg of elemental iron per serving alongside 150–300 mg of ascorbic acid. The ascorbate ligand maintains iron in its reduced ferrous (Fe²⁺) state, which is critical for absorption via the divalent metal transporter 1 (DMT1) in the duodenum. Bioavailability is estimated at 2–4× higher than ferric iron salts (e.g., ferric sulfate or ferric pyrophosphate) and approximately 20–30% greater than ferrous sulfate alone, owing to the chelation preventing oxidation to the poorly absorbed ferric (Fe³⁺) form and reducing precipitation by dietary phytates and tannins. Contains no macronutrients (protein, fat, carbohydrate, fiber) in meaningful amounts. The ascorbic acid component contributes modest antioxidant activity but is primarily functional as a bioavailability enhancer rather than a standalone vitamin C source at typical dosing.

Preparation & Dosage

Specific clinically studied dosage ranges for iron ascorbate were not provided in the available research. The compound is standardized to contain iron(2+) and L-ascorbic acid in a 1:2 molar ratio. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Iron ascorbate pairs well with Lactoferrin (100–200 mg), which facilitates iron uptake at the intestinal brush border via lactoferrin receptors and reduces GI side effects; Vitamin B12 (methylcobalamin, 500–1000 mcg) and Folate (5-MTHF, 400–800 mcg), both essential cofactors in erythropoiesis that work downstream of iron incorporation into hemoglobin, addressing multiple causes of anemia simultaneously; and Copper (as copper bisglycinate, 1–2 mg), which is required for ceruloplasmin-mediated ferroxidase activity that enables iron mobilization from stores into transferrin for systemic transport. Avoid concurrent intake with Calcium (>300 mg) or tannin-rich compounds, as these competitively inhibit DMT1 absorption and chelate iron respectively, negating the bioavailability advantage of the ascorbate complex.

Safety & Interactions

Iron ascorbate is generally well tolerated at standard therapeutic doses (providing 50–200 mg elemental iron daily), with common side effects including mild nausea, dark stools, and constipation, typically less frequent than with ferrous sulfate. It should not be co-administered with fluoroquinolone or tetracycline antibiotics, levodopa, methyldopa, or levothyroxine, as iron chelates these drugs in the GI tract and reduces their absorption by up to 50–90%; a 2-hour separation window is recommended. Iron ascorbate is contraindicated in hemochromatosis, hemosiderosis, hemolytic anemia without confirmed iron deficiency, and known hypersensitivity to ascorbic acid. It is considered safe in pregnancy when indicated for IDA and is commonly prescribed in the second and third trimesters, though high ascorbic acid doses above 2,000 mg/day should be avoided in pregnant women due to theoretical risk of rebound scurvy in neonates.